explore -WSS

explore

author：comprehensive 2025-09-28 02:26:49 - browse：32

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

focus

WSS

The health care issue Democrats can’t solve: hospital reform

Explaining an after

Kidney transplant patients stopped immunosuppressants in trial

After Sarepta trial failure, Duchenne families brace for more debate

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Bispecific antibodies are next new thing in cancer immunotherapy

knowledge

explore

focus

Bright Health sells Medicare Advantage business to Molina

Travis Kelce and the trap of celebrity vaccine endorsements

Jerome Adams on the need for new antivirals for Covid

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Walensky prepares to leave CDC — and Congress — behind

Travis Kelce and the trap of celebrity vaccine endorsements

Dobbs anniversary: the lost opportunity of abortion as health care

Prime Medicine says its gene editing passes test in monkeys

What does generative AI mean for health care? We asked experts

Coloradans with cystic fibrosis could lose access to Trikafta

hotspot

Novo: Oral version of Ozempic leads to 15% weight loss

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Timeline: Key moments in fight for gay rights

Biogen nominates mother of director’s child to replace him on board

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Medicare must police algorithms in Medicare Advantage, Dems say

explore

focus

entertainment

explore